Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    July 2017
  1. FABRIS E, Kilic S, Schellings DAAM, Ten Berg JM, et al
    Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction.
    Heart. 2017 Jul 5. pii: heartjnl-2017-311181. doi: 10.1136/heartjnl-2017-311181.
    PubMed     Text format     Abstract available


    June 2017
  2. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2017 Jun 29. pii: heartjnl-2017-311431. doi: 10.1136/heartjnl-2017-311431
    PubMed     Text format     Abstract available


  3. NDREPEPA G
    Psychological distress and mortality in stable coronary heart disease: persistence of high distress means increased risk.
    Heart. 2017 Jun 26. pii: heartjnl-2017-311610. doi: 10.1136/heartjnl-2017-311610
    PubMed     Text format    


  4. STIRRAT CG, Alam SR, MacGillivray TJ, Gray CD, et al
    Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction.
    Heart. 2017 Jun 22. pii: heartjnl-2016-311018. doi: 10.1136/heartjnl-2016-311018
    PubMed     Text format     Abstract available


  5. BIELINSKI SJ, Berardi C, Decker PA, Larson NB, et al
    Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310450. doi: 10.1136/heartjnl-2016-310450.
    PubMed     Text format     Abstract available


    May 2017
  6. LUIZ RIBEIRO A, Satoshi N, Catherine MO
    Heartbeat: Coronary heart disease, obesity, smoking and long-lasting psychological distress.
    Heart. 2017;103:644.
    PubMed     Text format    


    April 2017
  7. HOLTE E, Kleveland O, Ueland T, Kunszt G, et al
    Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
    Heart. 2017 Apr 21. pii: heartjnl-2016-310875. doi: 10.1136/heartjnl-2016-310875
    PubMed     Text format     Abstract available


  8. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    PubMed     Text format    


    March 2017
  9. ANDERSSON DP, Trolle Lagerros Y, Grotta A, Bellocco R, et al
    Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction.
    Heart. 2017 Mar 9. pii: heartjnl-2016-310746. doi: 10.1136/heartjnl-2016-310746.
    PubMed     Text format     Abstract available


  10. KUBLER P, Reczuch K
    Optimal stent treatment of cardiogenic shock complicating acute myocardial infarction: bare-metal or drug-eluting stent?
    Heart. 2017 Mar 3. pii: heartjnl-2016-311146. doi: 10.1136/heartjnl-2016-311146.
    PubMed     Text format    


  11. WARD-CAVINESS CK, Xu T, Aspelund T, Thorand B, et al
    Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.
    Heart. 2017 Mar 2. pii: heartjnl-2016-310789. doi: 10.1136/heartjnl-2016-310789.
    PubMed     Text format     Abstract available


    February 2017
  12. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    PubMed     Text format     Abstract available


    January 2017
  13. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    PubMed     Text format     Abstract available


  14. BUENO H, Pocock S, Danchin N, Annemans L, et al
    International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
    Heart. 2017;103:132-138.
    PubMed     Text format     Abstract available


  15. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    PubMed     Text format     Abstract available


  16. CHAPMAN AR, Adamson PD, Mills NL
    Assessment and classification of patients with myocardial injury and infarction in clinical practice.
    Heart. 2017;103:10-18.
    PubMed     Text format     Abstract available


    December 2016
  17. WILLIAMS RB
    Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications.
    Heart. 2016;102:2016.
    PubMed     Text format    


  18. REINDL M, Reinstadler SJ, Feistritzer HJ, Mueller L, et al
    Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
    Heart. 2016 Dec 15. pii: heartjnl-2016-310520. doi: 10.1136/heartjnl-2016-310520
    PubMed     Text format     Abstract available


  19. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.
    PubMed     Text format    


  20. JENKINS WS, Vesey AT, Stirrat C, Connell M, et al
    Cardiac alphaVbeta3 integrin expression following acute myocardial infarction in humans.
    Heart. 2016 Dec 7. pii: heartjnl-2016-310115. doi: 10.1136/heartjnl-2016-310115.
    PubMed     Text format     Abstract available


    November 2016
  21. LLOYD A, Steele L, Fotheringham J, Iqbal J, et al
    Pronounced increase in risk of acute ST-segment elevation myocardial infarction in younger smokers.
    Heart. 2016 Nov 29. pii: heartjnl-2016-309595. doi: 10.1136/heartjnl-2016-309595
    PubMed     Text format     Abstract available


  22. VIRTANEN M, Elovainio M, Josefsson K, Batty GD, et al
    Coronary heart disease and risk factors as predictors of trajectories of psychological distress from midlife to old age.
    Heart. 2016 Nov 18. pii: heartjnl-2016-310207. doi: 10.1136/heartjnl-2016-310207
    PubMed     Text format     Abstract available


  23. MCMULLAN CJ, Rimm EB, Schernhammer ES, Forman JP, et al
    A nested case-control study of the association between melatonin secretion and incident myocardial infarction.
    Heart. 2016 Nov 2. pii: heartjnl-2016-310098. doi: 10.1136/heartjnl-2016-310098.
    PubMed     Text format     Abstract available


  24. CHAPMAN AR, Anand A, Shah AS, Adamson PD, et al
    Response: a novel troponin I rule-out value below the upper reference limit for acute myocardial infarction.
    Heart. 2016;102:1772.
    PubMed     Text format    


    October 2016
  25. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    PubMed     Text format     Abstract available


    September 2016
  26. MACINTYRE CR, Mahimbo A, Moa AM, Barnes M, et al
    Influenza vaccine as a coronary intervention for prevention of myocardial infarction.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309983. doi: 10.1136/heartjnl-2016-309983
    PubMed     Text format     Abstract available


  27. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Text format     Abstract available


    August 2016
  28. SHAH R, Mooney MA
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335.
    PubMed     Text format    


  29. NAVARESE E, Kowalewski M
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335-6.
    PubMed     Text format    


  30. BRADLEY SM, Otto CM
    Heartbeat: Rule-out of acute myocardial infarction - risky business.
    Heart. 2016;102:1249-50.
    PubMed     Text format    


  31. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
    Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
    Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
    PubMed     Text format     Abstract available


  32. LINDAHL B, Jernberg T, Badertscher P, Boeddinghaus J, et al
    An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay.
    Heart. 2016 Aug 2. pii: heartjnl-2016-309951. doi: 10.1136/heartjnl-2016-309951.
    PubMed     Text format     Abstract available


  33. OTTO CM
    Heartbeat: Prediction of coronary disease risk with cardiac troponin in the general population.
    Heart. 2016;102:1151-2.
    PubMed     Text format    


    July 2016
  34. DI TANO G, Caretta G, De Maria R, Parolini M, et al
    Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
    PubMed     Text format     Abstract available


  35. DEVI R, Singh SJ, Powell J, Fulton EA, et al
    Cochrane Corner: are there benefits of using web-based interventions in the secondary prevention of coronary heart disease?
    Heart. 2016 Jul 21. pii: heartjnl-2015-309138. doi: 10.1136/heartjnl-2015-309138
    PubMed     Text format    


  36. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
    Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
    PubMed     Text format     Abstract available


    June 2016
  37. PARSONAGE WA, Mueller C, Greenslade JH, Wildi K, et al
    Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309270. doi: 10.1136/heartjnl-2016-309270
    PubMed     Text format     Abstract available


    May 2016
  38. PUDDU PE, Alexandre J
    Coronary heart disease and sexual activity.
    Heart. 2016 May 12. pii: heartjnl-2016-309505. doi: 10.1136/heartjnl-2016-309505
    PubMed     Text format    


  39. NORDMANN A, Schwartz G, Vale N, Bucher HC, et al
    Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
    Heart. 2016;102:653-4.
    PubMed     Text format    


    April 2016
  40. HEMKENS LG, Ewald H, Gloy VL, Arpagaus A, et al
    Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
    Heart. 2016;102:590-6.
    PubMed     Text format     Abstract available


  41. SHAVELLE DM
    Almanac 2015: coronary artery disease.
    Heart. 2016;102:492-9.
    PubMed     Text format     Abstract available


    March 2016
  42. BRICENO N, Schuster A, Lumley M, Perera D, et al
    Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.
    Heart. 2016;102:397-406.
    PubMed     Text format    


  43. BULLUCK H, Yellon DM, Hausenloy DJ
    Reducing myocardial infarct size: challenges and future opportunities.
    Heart. 2016;102:341-8.
    PubMed     Text format     Abstract available


  44. GAIBAZZI N
    Ultrasound contrast during stress echo: for obese patients, but not only.
    Heart. 2016;102:339-40.
    PubMed     Text format    


  45. TARKIA M, Stark C, Haavisto M, Kentala R, et al
    Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Heart. 2016;102:465-71.
    PubMed     Text format     Abstract available


  46. BUDOFF MJ
    Exercise capacity and biological age.
    Heart. 2016;102:415.
    PubMed     Text format    


  47. BLAHA MJ, Hung RK, Dardari Z, Feldman DI, et al
    Age-dependent prognostic value of exercise capacity and derivation of fitness-associated biologic age.
    Heart. 2016;102:431-7.
    PubMed     Text format     Abstract available


  48. ARRI SS, Ryan M, Redwood SR, Marber MS, et al
    Mental stress-induced myocardial ischaemia.
    Heart. 2016;102:472-80.
    PubMed     Text format    


  49. MISTRY A, McCann G, Skehan D
    Ischaemic chest pain in a 65-year-old man.
    Heart. 2016;102:471.
    PubMed     Text format    


    February 2016
  50. VELDERS MA, Abtan J, Angiolillo DJ, Ardissino D, et al
    Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
    Heart. 2016 Feb 4. pii: heartjnl-2015-308963. doi: 10.1136/heartjnl-2015-308963.
    PubMed     Text format     Abstract available


    January 2016
  51. FORDYCE CB, Douglas PS
    Optimal non-invasive imaging test selection for the diagnosis of ischaemic heart disease.
    Heart. 2016 Jan 29. pii: heartjnl-2015-307764. doi: 10.1136/heartjnl-2015-307764
    PubMed     Text format    


  52. AGUS AM, McKavanagh P, Lusk L, Verghis RM, et al
    The cost-effectiveness of cardiac computed tomography for patients with stable chest pain.
    Heart. 2016 Jan 14. pii: heartjnl-2015-308247. doi: 10.1136/heartjnl-2015-308247
    PubMed     Text format     Abstract available


  53. SHAH BN, Zacharias K, Pabla JS, Karogiannis N, et al
    The clinical impact of contemporary stress echocardiography in morbid obesity for the assessment of coronary artery disease.
    Heart. 2016 Jan 6. pii: heartjnl-2015-308796. doi: 10.1136/heartjnl-2015-308796.
    PubMed     Text format     Abstract available


  54. SINCLAIR H, Kunadian V
    Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes.
    Heart. 2016 Jan 6. pii: heartjnl-2015-307859. doi: 10.1136/heartjnl-2015-307859.
    PubMed     Text format     Abstract available


  55. CULLEN L, Greenslade JH, Carlton EW, Than M, et al
    Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain.
    Heart. 2016;102:120-6.
    PubMed     Text format     Abstract available


  56. GIANNITSIS E
    Sex-specific troponin measures for diagnosis of acute coronary syndrome.
    Heart. 2016;102:91-2.
    PubMed     Text format    


  57. TASEVSKA I, Enhorning S, Persson M, Nilsson PM, et al
    Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Heart. 2016;102:127-32.
    PubMed     Text format     Abstract available


    December 2015
  58. DASTIDAR AG, Rodrigues JC, Baritussio A, Bucciarelli-Ducci C, et al
    MRI in the assessment of ischaemic heart disease.
    Heart. 2015 Dec 30. pii: heartjnl-2014-306963. doi: 10.1136/heartjnl-2014-306963
    PubMed     Text format    


  59. SINTEK MA, Sparrow CT, Mikuls TR, Lindley KJ, et al
    Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308634. doi: 10.1136/heartjnl-2015-308634
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: